News

REIG JOFRE CLOSES 2024 WITH A RECORD NET PROFIT OF €10.5 MILLION, CONSOLIDATING ITS GLOBAL EXPANSION AND IMPROVING ITS PROFITABILITY

• REIG JOFRE closed 2024 with a 7% increase in revenue, reaching 339 million euros, driven by strong demand for dermatology and osteoarticular products, as well as antibiotics and injectables.
• The business outside Spain remains a key driver of growth, increasing by 13% and now accounting for 59% of total sales. Notably, a new subsidiary has been established in the Czech Republic.
• EBITDA grew by 8%, reaching 38 million euros, raising the EBITDA margin on sales to 11.2%, while the consolidated profit increased by 11%, reaching 10.5 million euros.
• Commitment to innovation and production capacity through investments worth 19.4 million euros and 6.6 million euros in Leanbio to strengthen vertical integration in biotechnology.
• These solid results bring REIG JOFRE closer to its goal of universalising the science that matters.

REIG JOFRE, (BME:RJF), a pharmaceutical company listed on the Spanish Stock Exchange (BME), closed 2024 with a solid rise in its business, consolidating its global expansion and improving its profitability. The company had a turnover of 339 million euros, an increase of 7% compared to 2023, driven by growing demand in its main areas of specialisation: antibiotics, high-tech sterile injectables and prescription products in dermatology and osteoarticular.

All-time record net profit

The growth was not only quantitative, but also strategic. Profitability improved significantly: operating profit grew by 20%, reaching 12.6 million euros, while EBITDA, with 8% growth, stood at 38 million euros, raising the EBITDA-to-sales ratio to 11.2%.

Net profits reached a record high of 10.5 million euros, an increase of 11% over the previous financial year, consolidating the company’s financial strength and reflecting the success of its optimisation and global expansion strategy.

Global expansion drives growth

Global expansion continues to drive the growth of REIG JOFRE, with a 13% increase in markets outside Spain, which represented 59% of total sales compared to 55% the previous year. This growth was achieved through a combination of direct sales by our own teams and strategic agreements with commercial partners. Markets outside Spain kept gaining relevance within the business, where expansion in Central Europe, Asia and strategic markets such as Sweden all merit mention. In 2024, in line with its expansion plan, REIG JOFRE strengthened its presence in Central Europe with the opening of a new subsidiary in the Czech Republic.

This international expansion not only diversifies income, but also reinforces the company’s aim of ensuring access to essential and innovative solutions across the globe.